Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Avalo Therapeutics Inc. buy Oppenheimer Holdings Inc.

Start price
€0.041
16.04.24 / 50%
Target price
-
16.04.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 16.04.25. The prediction end date can be changed by Oppenheimer_Holdings at any time.
Performance without dividends (%)
Name 1w
Avalo Therapeutics Inc. -
iShares Core DAX® 2.594%
iShares Nasdaq 100 3.553%
iShares Nikkei 225® 0.687%
iShares S&P 500 2.209%

Comments by Oppenheimer_Holdings for this prediction

In the thread Avalo Therapeutics Inc. diskutieren

Avalo Therapeutics, Inc. (NASDAQ: AVTX) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating.
Ratings data for AVTX provided by MarketBeat